A Survey On Enteral Feeding Formulas Market: Applications, Technology Trends and Challenges 2022 - 2027
                     MarketsandMarkets 
Presents
Enteral Feeding Formulas Market worth $8.2 billion by 2027
https://www.marketsandmarkets.com/Market-Reports/enteral-feeding-formulas-market-748
76393.html
The report "Enteral Feeding Formulas Market by Product (Polymeric, Elemental, 
Disease-specific), Stage (Adults, Pediatrics), Application (Oncology, Gastroenterology, 
Neurology, Hypermetabolism), End User (Hospitals, LTCF, Home care) - Global Forecast 
to 2027", is projected to reach USD 8.2 billion by 2027 from USD 5.2 billion in 2022, 
growing at a CAGR of 9.5% during the forecast period. 
Factors such as benefits of enteral nutrition over parenteral nutrition, increase in cost 
for healthcare expensis, rise in the number of preterm births, growing population of 
gerartric patients, increased prevalence of chronic diseases such as GI disorders, 
neurological disorders, Diabetses, etc., increased awareness of enteral nutrition in 
emerging countries are expected to improve market growth. However, rising cases of 
feeding and medication errors and underfeeding; and the complications associated 
with lack of skilled proffesionals are restricting the growth of this market to a certain 
extent. Also, insufficient or lack of reimbursements in some developing and 
underdeveloped countries and a dearth of trained physicians across the globe pose 
significant challenges for the growth of this market.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownload
Objectives of the Study:
• To validate the segmentation defined through the assessment of the product 
portfolios of the leading players in the market
• To understand key industry trends and issues defining the growth objectives of 
market players
• To gather both demand- and supply-side validation of the key factors affecting 
market growth, including market drivers, restraints, opportunities, and challenges
• To validate assumptions for the market sizing and forecasting model used for this 
market study
• To understand the market positions of the leading players in the enteral feeding 
formula market and their shares/rankings
• To understand the ongoing pricing trends in the market and future expectations
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst
The study categorizes the enteral feeding formula market based on 
product , stage, application, end user and regional & global level.
Global enteral feeding formula market, by Product
• Standard Formula
• Disease specific
• Diabetic Formula
• Renal Formula
• Hepatic Formula
• Pulmonary Formula
• Other Disease Specific Formula
• Peptide based formula
• Other Formula
Global enteral Feeding Formula Market, by Application
• Oncology
• Gastrointestinal Diseases
• Neurological Disorders
• Diabetes
• Other Applications
Abbott (US), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi (Germany), 
B. Braun Melsungen AG (Germany), Otsuka Holding Co. Ltd. (Japan), Nutritional 
Medicinals, LLC (US), Kate Farms (US), Medtrition Inc. (US), Victus, Inc. (US), Global 
Health Products, Inc. (US), Meiji Holdings Co., Ltd. (Japan), Reckitt Benckiser Group PLC. 
(UK), Hormel Foods Corporation (US), DermaRite Industries, LLC. (US), Medline 
Industries, LP. (US), Real Food Blends (US), and Ajinomoto Cambrooke, Inc. (US) and 
Among others
Companies Insight
Nestlé is a multinational health, nutrition, and wellness company. It manufactures and markets 
milk-based products, pharmaceuticals, baby foods and cereals, ophthalmic goods, and cooking 
aids. The company operates in seven major business segments—Powdered and Liquid 
Beverages, Petcare, Nutrition and Health Science, Prepared Dishes and Cooking Aids, Milk 
Products and Ice cream, Confectionary, and Water. The company provides a range of enteral 
feeding formulas through its Nestlé Health Science segment. In 2021, the Nestlé Health Science 
segment contributed the largest share of 5.5% to the company’s revenue, which was 3.9% in 
2020. The continuous growth of this segment is primarily due to its strong product portfolio, 
brand recognition, and high demand for nutritional formulas. In 2021 and 2022, the company 
acquired Orgain (US) and The Bountiful Company (US), which enabled the company to expand its 
presence in the market. The company operates in over 186 countries across Zone EMENA 
(Europe, Middle East, and North Africa), Zone AMS (The Americas), and Zone AOA (Asia, 
Oceania, and Africa).
Fresenius Kabi has a strong global footprint and focuses on providing high-quality, innovative 
clinical nutrition solutions. The company has a wide geographic presence in established markets 
and a broad product portfolio that includes nutritional supplements and tube feed & pediatric 
feed products. Along with this, Fresenius Kabi supports external development projects. The 
company also established the United for Clinical Nutrition (UFCN) initiative to raise awareness of 
disease-related malnutrition worldwide. This has enabled the company to expand its geographic 
presence.
Contact Us
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road, Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
Press release:
https://www.marketsandmarkets.com/PressReleases/enteral-feeding-
formulas.asp
Research insights:
https://www.marketsandmarkets.com/ResearchInsight/enteral-feedin
g-formulas-market.asp
About MarketsandMarkets
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche 
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. 
Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 
companies as clients. Almost 75,000 top officers across eight industries worldwide 
approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high 
growth markets following the "Growth Engagement Model – GEM". The GEM aims at 
proactive collaboration with the clients to identify new opportunities, identify most 
important customers, write "Attack, avoid and defend" strategies, identify sources of 
incremental revenues for both the company and its competitors. MarketsandMarkets™ 
now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, 
emerging companies, innovators, strategic players) annually in high growth emerging 
segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies 
this year for their revenue planning and help them take their innovations/disruptions 
early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, 
"RT" connects over 200,000 markets and entire value chains for deeper understanding 
of the unmet insights along with market sizing and forecasts of niche markets.